ERK1/2 pathway is involved in the invasive or migratory behavior of a number of malignancies, such as colon cancer, melanoma, breast cancer, and prostate cancer and this is well-established in previous studies [30]–[32]. Here, MAPK3 is linked to prostate carcinoma.